6533b829fe1ef96bd128ac1d

RESEARCH PRODUCT

Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer

Valentina GambardellaT. FleitasAndrés Cervantes

subject

OncologyImmunologic Factorsbusiness.industrymedicine.medical_treatmentImmune checkpoint inhibitorsCancer researchmedicineHematologyImmunotherapyAdvanced gastric cancerbusinesshttps://doi.org/10.1093/annonc/mdz008